Get started
Author

Daniel Koehler

Observed names: D. Koehler, Daniel KOEHLER, Daniel Köhler, Koehler, Daniel
ORCID: 0000-0002-7679-9627
Observed ORCID: 0000-0002-7679-9627
OpenAlex ID: A5048812428
Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen–radioguided Surgery
2022 · Sophie Knipper, Mehrdad Mehdi Irai, et al. · European Urology · 71
PDF
Skeletal muscle fat quantification by dual-energy computed tomography in comparison with 3T MR imaging
2021 · I. Molwitz, M. Leiderer, et al. · European Radiology · 43
PDF
Biochemical Response of <0.1 ng/ml Predicts Therapy-free Survival of Prostate Cancer Patients following Prostate-specific Membrane Antigen–targeted Salvage Surgery
2024 · Sophie Knipper, Flemming Lischewski, et al. · European Urology Oncology · 21
Delayed Imaging Improves Lesion Detectability in [99mTc]Tc-PSMA-I&S SPECT/CT in Recurrent Prostate Cancer
2023 · Christoph Berliner, Lisa Steinhelfer, et al. · Journal of Nuclear Medicine · 16
PDF
Feasibility of99mTc-MIP-1404 for SPECT/CT Imaging and Subsequent PSMA-Radioguided Surgery in Early Biochemically Recurrent Prostate Cancer: A Case Series of 9 Patients
2022 · Daniel Koehler, Markus Sauer, et al. · Journal of Nuclear Medicine · 14
PDF
Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer
2023 · Francesca AMBROSINI, Fabian FALKENBACH, et al. · Minerva Urology and Nephrology · 11
Robot-Assisted PSMA-Radioguided Salvage Surgery for Oligorecurrent Prostate Cancer Using the Novel SENSEI® Drop-in Gamma Probe: Correlation of Intraoperative Measurements to Preoperative Imaging and Final Histology
2024 · Giovanni Mazzucato, Fabian Falkenbach, et al. · Cancers · 8
PDF
Tumor Response Evaluation Using iRECIST: Feasibility and Reliability of Manual Versus Software-Assisted Assessments
2024 · Inka Ristow, Lennart Well, et al. · Cancers · 7
PDF
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer
2023 · Fabian Falkenbach, Francesca Ambrosini, et al. · Cancers · 7
PDF
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support
2023 · Fabian Falkenbach, Sophie Knipper, et al. · World Journal of Urology · 7
PDF
Evaluation of [68 Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antigen recurrence using the PROMISE criteria
2022 · Daniel Koehler, Markus Sauer, et al. · EJNMMI Research · 7
PDF
Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer
2024 · Fabian Falkenbach, Marie‐Lena Schmalhofer, et al. · The Prostate · 6
PDF
PSMA hybrid imaging in prostate cancer – current applications and perspectives
2023 · Daniel Koehler, Christoph Berliner, et al. · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 6
PDF
Infectious complications of radiologically placed upper arm ports: A single center analysis
2023 · Daniel Koehler, Jan-Marcus Haus, et al. · PLoS ONE · 5
PDF
Overview of selected completed prospective studies on PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
2025 · Amir Karimzadeh, Wencke Lehnert, et al. · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 3
PDF
Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysis
2023 · Daniel Koehler, Samuel Trappe, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 3
PDF
Deradicalisation in Germany: preventing and countering violent extremism
2021 · Daniel Koehler · Revista CIDOB d Afers Internacionals · 3
Age-Related Outcomes of [177Lu]Lu-PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Retrospective Analysis
2025 · Nikolaus Schweigert, Nadja Strewinsky, et al. · Cancers · 2
PDF
Perspective transition from transrectal to transperineal MRI-fusion biopsy under local anesthesia – the institutional TREXIT learning curve of the new gold standard
2025 · Fabian Falkenbach, Lukas Hohenhorst, et al. · Prostate Cancer and Prostatic Diseases · 2
Time series analysis of the in-hospital diagnostic process in suspected pulmonary embolism evaluated by computed tomography: An explorative study
2021 · Daniel Koehler, Ann-Kathrin Ozga, et al. · European Journal of Radiology · 2
Time series analysis of the demand for COVID-19 related chest imaging during the first wave of the SARS-CoV-2 pandemic: An explorative study
2021 · Daniel Koehler, Ann-Kathrin Ozga, et al. · PLoS ONE · 2
PDF
Influencing factors on the time to CT in suspected pulmonary embolism: an explorative investigation
2024 · Daniel Koehler, Ann-Kathrin Ozga, et al. · Scientific Reports · 1
PDF
Prostatic acid phosphatase: a rediscovered target in prostate cancer
2026 · Daniel Koehler, Tobias Maurer · Nature Reviews Urology
Overview of selected completed prospective studies on PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
2025 · Amir Karimzadeh, Wencke Lehnert, et al. · Nuklearmedizin - NuclearMedicine
Bimekizumab rescue therapy in a patient with relapsing polychondritis-associated aortitis
2025 · Phillip Kremer, Simon Melderis, et al. · EULAR Rheumatology Open
Works count: 30
Citation count: 247
H-index: 7
I10-index: 6
Year
Topic
Type